arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

UFP Technologies, Inc.

UFPT Health Care Medical/Dental Instruments
$289.36
▲ +0.2% Today
as of Sep 4, 16:55 ET
Last 30 days +11.90% Jul 28 → Sep 04
$248.38 $271.59 $294.81 $318.03 $341.24 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$285.00
High
$290.46
Low
$285.00
Volume
$105,028
Avg Vol
$176,584
Mkt Cap
$2.5B
P/E (TTM)
58.70
Beta
—
52w High
$338.71
52w Low
$173.86
Div Yield
—
Shares Out
$8M

Recent Press Releases & News last 60 days · 24 items

Sep 3 · 10:11 Insider Monkey
UFP Technologies (UFPT) Posts Record Profits, But The Margin Story Gets Complicated
Aug 31 · 21:10 Motley Fool
UFP Technologies Director Cynthia Feldmann Sells 1,000 Shares
Aug 28 · 22:01 MarketBeat
UFP Technologies Targets 12%-18% Growth as Medical Device M&A Pipeline Builds
▸ Show all 24 press releases & news Free account →

Overview

52-week range
$174
$339
70% of range
Avg surprise (last 3)
+14.5%
Avg reaction (last 2)
+5.2%
50% positive
Latest IV / EM
34%
EM ±5.4% · $290 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$2.05$2.21$2.37$2.52$2.68 Actual $2.47Est $2.05Actual $2.50Est $2.29Actual $2.48Est $2.18Actual $2.68 Mar/2025Jun/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$0$46M$91M$137M$183M Mar 25Jun 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $2.68 — — — — financials
Mon May 4, 2026Mar/2026 $2.48 $2.18 +13.8% +0.4% -0.8% earnings
Mon Aug 4, 2025Jun/2025 $2.50 $2.29 +9.2% — — earnings
Tue May 6, 2025Mar/2025 $2.47 $2.05 +20.5% — +11.2% earnings

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$174M$154M——$151M$148M——
Cost of revenue$123M$110M—$112M$108M$106M—$104M
Gross profit$51M$44M——$44M$42M——
Operating income$28M$23M—$23M$24M$23M—$25M
Net income$21M$17M——$17M$17M——
EPS (diluted)$2.68$2.24——$2.21$2.21——

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$9M$20M$20M$18M$15M$14M$13M$16M
Inventory$100M$94M$87M$86M$85M$90M$88M$89M
Total current assets$235M$224M$201M$198M$191M$206M$195M$201M
Total assets$682M$675M$655M$653M$635M$643M$629M$639M
Long-term debt$105M$125M$123M$134M$151M$164M$177M$200M
Total liabilities$219M$236M$231M$249M$249M$282M$286M$309M
Total equity$462M$439M$424M$404M$385M$361M$343M$329M

Implied volatility — last 90 days

31%49%68%87%105% Jun 07 — IV 52% · EM ±7.1%Jun 08 — IV 47% · EM ±6.2%Jun 09 — IV 48% · EM ±6.1%Jun 10 — IV 48% · EM ±5.6%Jun 11 — IV 42% · EM ±4.6%Jun 12 — IV 54% · EM ±5.6%Jun 15 — IV 68% · EM ±4.9%Jun 16 — IV 73% · EM ±4.3%Jun 17 — IV 106% · EM ±4.4%Jun 19 — IV 38% · EM ±8.4%Jun 22 — IV 41% · EM ±8.6%Jun 23 — IV 40% · EM ±8.1%Jun 24 — IV 37% · EM ±7.4%Jun 25 — IV 38% · EM ±7.5%Jun 26 — IV 33% · EM ±6.3%Jun 29 — IV 36% · EM ±6.4%Jun 30 — IV 36% · EM ±6.2%Jul 01 — IV 34% · EM ±5.6%Jul 02 — IV 35% · EM ±5.6%Jul 03 — IV 36% · EM ±5.6%Jul 06 — IV 37% · EM ±5.2%Jul 07 — IV 39% · EM ±5.1%Jul 08 — IV 41% · EM ±5.2%Jul 09 — IV 41% · EM ±4.8%Jul 10 — IV 46% · EM ±5.1%Jul 13 — IV 56% · EM ±4.7%Jul 14 — IV 61% · EM ±4.4%Jul 15 — IV 97% · EM ±5.7%Jul 16 — IV 94% · EM ±3.9%Jul 20 — IV 49% · EM ±11.5%Jul 21 — IV 49% · EM ±11.5%Jul 22 — IV 49% · EM ±11.1%Jul 23 — IV 50% · EM ±11.2%Jul 24 — IV 49% · EM ±10.9%Jul 27 — IV 49% · EM ±10.3%Jul 28 — IV 49% · EM ±10.1%Jul 29 — IV 50% · EM ±9.9%Jul 30 — IV 48% · EM ±9.4%Jul 31 — IV 51% · EM ±9.8%Aug 03 — IV 49% · EM ±8.7%Aug 04 — IV 39% · EM ±6.7%Aug 05 — IV 38% · EM ±6.3%Aug 06 — IV 36% · EM ±5.8%Aug 07 — IV 35% · EM ±5.4%Aug 10 — IV 36% · EM ±5.0%Aug 11 — IV 33% · EM ±4.4%Aug 12 — IV 34% · EM ±4.2%Aug 13 — IV 31% · EM ±3.7%Aug 14 — IV 31% · EM ±3.5%Aug 17 — IV 39% · EM ±3.3%Aug 18 — IV 70% · EM ±5.1%Aug 19 — IV 57% · EM ±3.4%Aug 20 — IV 87% · EM ±3.6%Aug 24 — IV 34% · EM ±7.2%Aug 25 — IV 34% · EM ±6.9%Aug 26 — IV 34% · EM ±6.9%Aug 27 — IV 33% · EM ±6.4%Aug 28 — IV 31% · EM ±6.0%Aug 31 — IV 33% · EM ±5.8%Sep 01 — IV 34% · EM ±5.8%Sep 02 — IV 35% · EM ±5.8%Sep 03 — IV 34% · EM ±5.5%Sep 04 — IV 34% · EM ±5.4%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in